Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Clinical Trials Network  

The Autism Clinical Trials Network (ACTN) is a collaboration of treatment and research centers dedicated to accelerating clinical trials of investigational treatments for autism and to increasing the number of biological treatments available to families and clinicians. The ACTN was officially launched in 2005 to focus on translational research, the critical step necessary to transfer findings from the laboratory to clinical application. By facilitating data-sharing and multi-center trials, the goal of the network will be to test the efficacies of treatment approaches as well as to rapidly screen new promising compounds that emerge from biomedical research, significantly decreasing the time and amount of money needed to develop them. Project Status
ONGOING

2010

Funder Autism Speaks
Fiscal Year Funding $0.00
Current Award Period Ongoing
Project Number n/a
Principal Investigator Staff Member
Received ARRA Funding? No
Strategic Plan Question Question 4: Which Treatments And Interventions Will Help? (Treatments)
Subcategory Medical/Pharmacologic
Strategic Plan Objective Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4LA. Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.
Federal or Private? Private
Institution Autism Speaks (AS)
State/Country New York
Web Link 1 Clinical Trials Network (External web link)
Web Link 2 No URL available.
Web Link 3 No URL available.
New! History/Related Projects Clinical Trials Network | $121,843.00 | 2009 | Project number unavailable
Clinical Trials Network (CTN) | $200,000.00 | 2008 | Project number unavailable